Pericapsular Nerve Block and Iliopsoas Fascial Plane Block in Hip Surgery

Launched by HASEKI TRAINING AND RESEARCH HOSPITAL · Feb 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different types of pain relief techniques used during and after hip surgery. Specifically, the researchers want to see how effective the pericapsular nerve block (PENG) and the iliopsoas block (IPB) are in managing pain and allowing patients to move normally after their operation. The main goal is to find out which method provides better pain control and preserves movement for patients recovering from hip fractures.

To participate in this study, individuals must be between 18 and 90 years old and scheduled for a total hip replacement surgery. They should also be in generally good health, as defined by a specific medical classification. Participants will receive standard anesthesia during surgery and then one of the two pain relief techniques afterwards. Throughout the first day after surgery, the researchers will check how much pain relief each patient needs and assess their ability to move. This study is currently recruiting, and anyone considering participation should discuss it with their healthcare provider to see if they meet the eligibility criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients eligible for inclusion in this study were those aged 18 to 90 years who had undergone total hip arthroplasty surgery and had an American Society of Anesthesiologists (ASA) Physical Status classification of I to III and body mass index (BMI) between 18 and 30 kg/m2.
• Exclusion Criteria:
• • Patients were excluded if they had one of the following criteria: refusal to participate, a history of neurological deficits or neuropathy affecting the lower extremity, infection at the site of block application, coagulopathy; allergy to local anaesthetics, epilepsy or treatment with antipsychotics; abuse of alcohol or drugs; previous surgery distorting the anatomy of the inguinal or supra inguinal areas; severe organ dysfunction ( kidney, liver and other); uncooperative patients who fail to respond reliably to verbal pain assessment.